Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
08/1995
08/24/1995CA2181367A1 Novel opioid peptides for the treatment of pain and use thereof
08/23/1995EP0668278A1 Adhesion receptor antagonists
08/23/1995EP0668075A2 Non-peptide tachykinin receptor antagonists
08/23/1995EP0668074A1 Pharmaceutical composition
08/23/1995EP0667911A1 Stably-transformed mammalian cells expressing a regulated, inflammatory cyclooxygenase
08/23/1995EP0667901A1 Novel cytokine
08/23/1995EP0667870A1 COMPOSITIONS AND METHODS FOR MODIFYING THE REGULATORY ACTIVITY OF TGF-$g(b)
08/23/1995EP0667857A1 Indolylcarbamates as anti-inflammatory agents
08/23/1995EP0667856A1 Novel vitamin d analogues
08/23/1995EP0667855A1 Substituted arylalkynyl- and heteroarylalkynyl-n-hydroxyurea inhibitors of leukotriene biosynthesis
08/23/1995EP0667854A1 Peptidyl activated ketone inhibitors containing natural and unnatural peptide sequences
08/23/1995EP0667784A1 Inhibitors of cell regulatory factors and methods for preventing or reducing scarring
08/23/1995EP0667780A1 Purified ceramide-activated protein kinase, assay for identifying agents which act on same, and methods of using said agents
08/23/1995EP0667770A1 Inhibition of tnf production.
08/23/1995EP0371036B1 Method of reducing tissue damage at an inflammatory site using a monoclonal antibody
08/23/1995CN1107159A Linear adhesion inhibitors
08/23/1995CN1107149A 哌嗪衍生物 Piperazine derivatives
08/23/1995CN1107137A Novel carboxylate derivatives exhibiting phospholipase A2 inhibitery a ctivity
08/23/1995CN1107042A Inclusion complex
08/22/1995US5444153 Plasminogen activator inhibitor which has been altered to eliminate a protease sensitive site
08/22/1995US5444072 Useful in treatment of autoimmune disorders, psoriasis, inflammatory diseases, rheumatoid arthritis
08/22/1995US5444050 Binding of E-selectin or P-selectin to sialyl Lewisx or sialyl-Lewisa
08/22/1995US5444043 Cyclic depsipeptide non-steroidal antiinflammatory agent
08/22/1995US5443839 Liposomes containing scutellaria extracts
08/22/1995US5443833 Pharmaceutical compositions
08/22/1995CA2022516C Saccharide derivatives of protocatechualdehyde
08/20/1995CA2142741A1 Adhesion receptor antagonists
08/19/1995CA2142315A1 Drug
08/17/1995WO1995021915A1 Ligand (act-4-l) to a receptor on the surface of activated cd4+ t-cells
08/17/1995WO1995021855A1 Diastereomeric pure trifluoromethyl ketone peptide derivatives as inhibitors of human leukocyte elastase
08/17/1995WO1995021843A1 Azacyclic derivatives
08/17/1995WO1995021842A1 Heterocyclic compounds and their preparation and use
08/17/1995WO1995021821A1 New compounds with analgesic and local anaesthetic effect
08/17/1995WO1995021819A1 Aralkoxy and aralkylthio substituted azacyclic compounds as tachykinin antagonists
08/17/1995WO1995021817A1 Substituted spiro compounds for the treatment of inflammation
08/17/1995WO1995021610A1 Use of derivatives of 2,4-bisubstituted phenols as 5-lipoxigenase inhibitors
08/17/1995WO1995021601A2 Kallikrein-inhibiting 'kunitz domain' proteins and analogues thereof
08/17/1995CA2183066A1 Ligand (act-4-l) to a receptor on the surface of activated cd4+ t-cells
08/17/1995CA2182957A1 Heterocyclic compounds and their preparation and use
08/17/1995CA2182950A1 Substituted spiro compounds for the treatment of inflammation
08/17/1995CA2182734A1 Aralkoxy and aralkylthio substituted azacyclic compounds as tachykinin antagonists
08/17/1995CA2181068A1 New compounds with analgesic and local anaesthetic effect
08/17/1995CA2180006A1 Diastereomeric pure trifluoromethyl ketone peptide derivatives as inhibitors of human leukocyte elastase
08/16/1995EP0666914A1 Novel p-selectin ligand protein
08/16/1995EP0666867A1 Reagents and methods for treating rheumatoid arthritis
08/16/1995EP0666861A1 Rapamycin arylcarbonyl and alkoxycarbonyl carbamates as immunosuppressive and antifungal agents
08/16/1995EP0666856A1 4-arylmethyloxymethyl piperidines as tachykinin antagonists
08/16/1995EP0666849A1 Aryl and heteroarylmethoxyphenyl inhibitors of leukotriene biosynthesis
08/16/1995EP0666846A1 New substituted azetidinones as anti-inflammatory and antidegenerative agents
08/16/1995EP0666758A1 Anti-inflammatory tolerogenic and immunoinhibiting properties of carbohydrate binding-peptides
08/16/1995EP0666757A1 Anti-inflammatory, tolerogenic and immunostimulatory properties of carbohydrate binding-proteins
08/16/1995EP0666750A1 Mixtures or complexes containing calcium and sulfate
08/16/1995EP0666741A1 Dithiocarbamates for the treatment of atherosclerosis and other cardiovascular and inflammatory diseases
08/16/1995EP0371999B1 Nucleic acid and methods for the synthesis of novel fusion polypeptides with a phospholipid anchor domain
08/16/1995EP0335901B1 Pentigetide for treating non-IgE-mediated inflammatory diseases
08/16/1995CN1106806A Adhesion receptor antagonists
08/16/1995CN1106801A Isoquinolines
08/16/1995CN1106656A Sustained release drug formulation containing a tramadol salt
08/15/1995US5442110 Connective tissue disorders
08/15/1995US5441977 Immunosuppressive agent; for treating transplant rejection
08/15/1995US5441976 Immunostimulants
08/15/1995US5441960 1-pyrimidinylacetamide human leukocyte elastate inhibitors
08/15/1995US5441953 4- amino derivatives of mycophenolic acid
08/15/1995US5441932 Antiallergens, antiinflammatory agents
08/15/1995CA2007480C Use of the active substance azelastine for the control of psoriasis disorders and inflammatory disorders
08/10/1995WO1995021251A1 T-cell antigens, and their use in diagnosis and treatment of t-cell mediated conditions
08/10/1995WO1995021187A1 Cyclic neurokinin a antagonists
08/10/1995WO1995021180A1 Substituted lactose derivatives as cell adhesion inhibitors
08/10/1995WO1995020959A1 Use of sialic acid or antibodies to sialidase as anti-infectious agents and anti-inflammatory agents
08/10/1995CA2182685A1 T-cell antigens, and their use in diagnosis and treatment of t-cell mediated conditions
08/10/1995CA2182007A1 Substituted lactose derivatives as cell adhesion inhibitors
08/09/1995EP0666080A1 Treatment of autoimmune diseases by oral administration of autoantigens
08/09/1995EP0665844A1 Substituted benzylaminoquinuclidines as substance p antagonists
08/09/1995EP0665843A1 Substituted quinuclidines as substance p antagonists
08/09/1995EP0665830A1 Tilidin dihydrogen orthophosphate, method of preparing it and pharmaceutical preparations containing it.
08/09/1995EP0665729A1 Biocompatible polymers containing diagnostic or therapeutic moieties
08/09/1995EP0538416B1 Substituted monocyclic aryl compounds exhibiting selective leukotriene b 4 antagonist activity
08/09/1995EP0425650B1 Anti-inflammatory 4-aminophenol derivatives
08/09/1995CN1106398A Esculetin derivatives, process for manufacture and use thereof, and pharmaceutical composition
08/08/1995US5440046 Angiotensin antagonist, hypotensive agent
08/08/1995US5440035 Leukotriene antagonists; antiallergens, antiinflammatory agents
08/08/1995US5440015 Selectin peptide medicaments for treating disease
08/08/1995US5439940 Benz[e]indene derivatives
08/08/1995US5439937 Antiinflammatory agent
08/08/1995US5439929 Bicyclic carbamates, pharmaceutical compositions and use
08/08/1995US5439927 For potassium channel opening, hypotensive agents, broncho- or vasodilators, gastrointestinal disorders
08/08/1995US5439925 Di(aromatic) compounds and their use in human and veterinary medicine and in cosmetics
08/08/1995US5439895 4-aminoquinazoline derivatives
08/03/1995WO1995020581A1 Novel human leukocyte elastase (hle) inhibitors, and related pharmaceutical compositions and methods of use
08/03/1995WO1995020578A1 SUBSTITUTED AROMATIC COMPOUNDS AS c.AMP PHOSPHODIESTERASE- AND TNF-INHIBITORS
08/03/1995WO1995020575A1 Aralkylamino substituted azacyclic therapeutic agents
08/03/1995WO1995020564A1 Leukotriene b4 derivatives, methods of preparing them and their use as drugs
08/03/1995WO1995020563A1 New leukotriene b4 derivatives, methods of preparing them and their use as drugs
08/03/1995WO1995020396A1 Inhibitors of geranylgeranyl-protein transferase
08/03/1995WO1995020395A1 Atopic disease remedy
08/03/1995WO1995020390A1 Use of vanadium molybdenum or tungsten complexes for controlling cellular proliferation
08/03/1995WO1995020385A1 Inhibition of arthritis by l-type calcium channel antagonists
08/03/1995WO1995004720A3 Gastrin and cck receptor ligands
08/03/1995CA2182203A1 Novel human leukocyte elastase (hle) inhibitors, and related pharmaceutical compositions and methods of use
08/03/1995CA2182114A1 Inhibition of arthritis by l-type calcium channel antagonists
1 ... 1169 1170 1171 1172 1173 1174 1175 1176 1177 1178 1179 1180 1181 1182 1183 1184 1185 1186 1187 1188 1189 ... 1272